TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
VCEL

Vericel Corp Ord

Healthcare · Biotechnology

39.60$ -1.2% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

Vericel Corp Ord (VCEL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 77 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement VCEL
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
46 65 51 53 58 75 53 63 68 93 68 77 306
15 16 16 16 16 17 16 17 18 20 19 21 78
31 49 35 37 42 58 36 47 50 73 49 56 228
5.7 4.9 6.4 7.4 6.1 4.9 7.3 6.7 6.3 7.3 8.1 7.5 29
30 31 34 35 38 35 42 42 40 43 49 48 181
36 36 41 43 44 40 49 49 46 51 57 56 210
-5.1 13 -5.5 -6.0 -2.5 18 -13 -2.0 3.5 22 -8.1 0.4 18
0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.6
-3.9 14 -3.9 -4.7 -0.9 20 -11 -0.6 5.1 24 -6.3 2.2 25
-0.3 1.1 1.3 0.1 0.9
-3.7 13 -3.9 -4.7 -0.9 20 -11 -0.6 5.1 23 -6.3 2.2 24
-2.6 15 -2.3 -3.2 0.6 22 -8.4 2.4 8.2 28 -2.9 5.6 38

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?